COMP <GO>
MDXG vs UNH // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
MiMedx Group Inc (NASDAQ) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: MDXG 9
— UNH 4
■ METRIC PARITY
LAST: $3.97 (+0.51%) • MKT CAP: $579.3M
options-implied-move
—
LAST: $410.91 (+0.94%) • MKT CAP: $368.83B
options-implied-move
6.74%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MDXG VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MDXG | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 82.60% | 88.57% | -5.97 | UNH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 47.20% | 11.47% | +35.73 | MDXG | /roic <GO> |
| EV/EBITDA & P/E Valuation | 6.7x | 16.4x | -9.75 | MDXG | /valuation <GO> |
| Free Cash Flow Yield | 12.77% | 6.48% | +6.29 | MDXG | /fcf-yield <GO> |
| Operating Margin | 15.30% | 4.82% | +10.48 | MDXG | /operating-margins <GO> |
| Net Profit Margin | 11.60% | 3.14% | +8.46 | MDXG | /net-margins <GO> |
| Revenue Growth (YoY) | 20.00% | 6.46% | +13.54 | MDXG | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.28% | -2.28 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 6.45 | 3.12 | +3.33 | MDXG | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 7/9 | +2.00 | MDXG | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | — | 6.74% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 32.9 | 59.2 | -26.33 | UNH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.33 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 10.0x | 17.1x | -7.09 | MDXG | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $579.3M | $368.83B | -$368.25B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MDXG REV | UNH REV | MDXG GROSS % | UNH GROSS % | MDXG FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $418.6M | $447.57B | 82.6% | 88.7% | $74.0M | $16.07B |
| FY 2024 | $348.9M | $400.28B | 82.8% | 88.3% | $66.2M | $20.70B |
| FY 2023 | $321.5M | $371.62B | — | 89.6% | $26.8M | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MDXG // BETA —
UNH // BETA 0.33